Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amita Gupta

Showing results (261-270 of 328) with videos related to

Pageof 33
Sort By:
Scientific Reports|May 12, 2023
A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interactionArtur T L Queiroz, Caian L Vinhaes, Eduardo R Fukutani, et al.
Open Forum Infectious Diseases|January 31, 2022
Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, IndiaJeffrey A Tornheim, Zarir F Udwadia, Prerna R Arora, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 24, 2015
Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adultsRupak Shivakoti, Parul Christian, Wei-Teng Yang, et al.
Contemporary Clinical Trials|September 24, 2025
Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trialMichelle A Kendall, Michael D Hughes, Soyeon Kim, et al.
The Lancet. Child & Adolescent Health|August 27, 2023
Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trialAmita Gupta, Priya Singh, Lisa Aaron, et al.
BMC Medicine|September 25, 2018
Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control studyRupak Shivakoti, Nikhil Gupte, Srikanth Tripathy, et al.
Plos One|August 2, 2018
Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden settingPadmapriyadarsini Chandrasekaran, Vidya Mave, Kannan Thiruvengadam, et al.
JAMA Network Open|March 25, 2025
Risk Factors for Health Care-Associated Bloodstream Infections in NICUsJulia Johnson, Sudhir Malwade, Sharad Agarkhedkar, et al.
Frontiers in Tuberculosis|April 30, 2025
Clinical and laboratory risk factors for pulmonary tuberculosis recurrence in three pooled Indian cohortsSonya Krishnan, Nikhil Gupte, Mandar Paradkar, et al.
The Journal of Infectious Diseases|December 2, 2015
Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained SettingsRupak Shivakoti, Wei-Teng Yang, Sima Berendes, et al.
Pageof 33

Showing results (261-270 of 328) with videos related to

Sort By:
Pageof 33
Scientific Reports|May 12, 2023
A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interactionArtur T L Queiroz, Caian L Vinhaes, Eduardo R Fukutani, et al.
Open Forum Infectious Diseases|January 31, 2022
Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, IndiaJeffrey A Tornheim, Zarir F Udwadia, Prerna R Arora, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 24, 2015
Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adultsRupak Shivakoti, Parul Christian, Wei-Teng Yang, et al.
Contemporary Clinical Trials|September 24, 2025
Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trialMichelle A Kendall, Michael D Hughes, Soyeon Kim, et al.
The Lancet. Child & Adolescent Health|August 27, 2023
Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trialAmita Gupta, Priya Singh, Lisa Aaron, et al.
BMC Medicine|September 25, 2018
Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control studyRupak Shivakoti, Nikhil Gupte, Srikanth Tripathy, et al.
Plos One|August 2, 2018
Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden settingPadmapriyadarsini Chandrasekaran, Vidya Mave, Kannan Thiruvengadam, et al.
JAMA Network Open|March 25, 2025
Risk Factors for Health Care-Associated Bloodstream Infections in NICUsJulia Johnson, Sudhir Malwade, Sharad Agarkhedkar, et al.
Frontiers in Tuberculosis|April 30, 2025
Clinical and laboratory risk factors for pulmonary tuberculosis recurrence in three pooled Indian cohortsSonya Krishnan, Nikhil Gupte, Mandar Paradkar, et al.
The Journal of Infectious Diseases|December 2, 2015
Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained SettingsRupak Shivakoti, Wei-Teng Yang, Sima Berendes, et al.
Pageof 33